DiscoveRx Corporation Ltd

DiscoverX Solutions for Drug Discovery, a part of Eurofins, is a company that provides products and services to support the drug discovery and development process. The company's core business is centered around cell line assay kits, which are designed to help scientists accelerate their research and development of new therapeutics. These kits include stable cell lines, assay reagents, and detection reagents that are optimized for precision, reproducibility, and efficiency. DiscoverX offers a comprehensive portfolio of over 1,000 cell line assay kits that cover a broad range of drug targets, including GPCRs, kinases, checkpoint receptors, and more. The company's products and services are used by biopharmaceutical companies worldwide to support discovery and development in various therapeutic areas, including oncology, metabolic disease, inflammation, and neurological disorders. DiscoverX also offers custom development capabilities for custom cell lines, assays, and enzyme development, as well as an early access program that provides researchers with access to innovative cell lines and ready-to-use assays before they are publicly available.

DiscoveRx Corporation develops, manufactures, and commercializes reagents and assay kits for the drug discovery and screening markets internationally. It offers EFC-based HitHunter cAMP assays for GPCR screening applications; and PathHunter technology, an assay system that enables in vivo cell-based assays for pathway profiling and screening.